Credit rating agency, CARE has assigned ‘D’ rating to Sterling Biotech’s long-term bank facilities worth Rs 3768 crore. The rating agency has also assigned ‘D’ rating to the company’s short-term bank facilities worth Rs 69.68 crore. The ratings reflect on-going delays in servicing of interest and default in repayment of debt obligation by the company on account of its weakened liquidity position.
Sterling Biotech is mainly engaged in the manufacturing of pharmaceutical grade gelatin, which has wide range of applications such as capsules, tablets, etc. It is one of the leading manufacturers of pharmaceutical grade gelatin in India with good presence in USA, which is the largest market for Pharmaceuticals.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: